Abstract: Disclosed is a topical anhydrous, homogenous pharmaceutical composition for treating skin disorder and wounds comprising cod liver oil, hempseed oil, monolaurin, medium chain triglycerides (“MCT”), free fatty acids, sea salt, and vegetable oil selected from the group consisting of red palm concentrate, coconut oil, and red palm oil and combination thereof and optionally fish collagen, ascorbyl palmitate, thickening agent, such as beeswax, red palm concentrate and cetyl ester.
Type:
Grant
Filed:
April 12, 2019
Date of Patent:
February 20, 2024
Assignee:
Omeza Holdings, Inc.
Inventors:
Griscom Bettle, III, John Harlin, Thomas Gardner
Abstract: The present disclosure describes a novel anhydrous topical pharmaceutical composition comprised of marine oil, such as fish oil or algae oil; vegetable oil having a an omega3 fat content greater than 9 wt %, such as hempseed oil, canola oil, flax seed oil, or cannabidiol; monolaurin, cetyl esters or wax; and medium chain triglycerides (“MCT”), and optionally fish collagen. The composition is useful for treating wounds, burns and skin conditions.
Type:
Application
Filed:
April 20, 2021
Publication date:
June 1, 2023
Applicant:
OMEZA HOLDINGS, INC.
Inventors:
Griscom BETTLE, III, Michael C. INMAN, Sarah M. KITLOWSKI